A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes.

An exogenous insulin administration-modified, frequently sampled iv glucose tolerance test (FSIGT) for application in insulin-dependent diabetic patients (IDDM) to allow for estimation of insulin sensitivity (SI) and glucose effectiveness (SG) with Bergman's minimal model of glucose kinetics was investigated. An insulin infusion protocol (either 4 or 8 mU/min.kg from 20-25 min) was compared to the standard tolbutamide-modified (300 mg at 20 min) FSIGT in normal control subjects. SI and SG were not different for the insulin infusion- and tolbutamide-modified protocols [SI, 2.8 +/- 0.4, 3.6 +/- 0.6, and 2.5 +/- 0.5 X 10(4) min1/(microU/mL), respectively]. SI and SG were quantified in insulin-requiring newly diagnosed IDDM and in noninsulin-requiring IDDM in clinical remission with the exogenous insulin administration protocol. Both SI and SG were reduced in newly diagnosed IDDM compared to normal controls (by 64% and 40%, respectively). SI was normalized in IDDM in clinical remission despite a continued poor insulin secretory response to both glucose and tolbutamide. Although SI was normal in patients in clinical remission, SG remained reduced (by 65%) compared to that in normal controls. In conclusion, our results demonstrate that modification of the FSIGT with the exogenous administration of insulin allows for estimation of insulin sensitivity and glucose effectiveness in IDDM patients. Comparison to the standard protocol in normal subjects suggests that this results in valid measurements of insulin sensitivity and glucose effectiveness. Results of the application of this protocol in IDDM were consistent with previous observations that insulin sensitivity is reduced in poorly controlled IDDM and normalized in well controlled patients. Glucose effectiveness was found to be reduced in all IDDM subjects regardless of the degree of control.

[1]  G. Reaven,et al.  Enhanced Glucose Utilization During Prolonged Glucose Clamp Studies , 1981, Diabetes.

[2]  H. Yki-Järvinen,et al.  Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. , 1984, The Journal of clinical endocrinology and metabolism.

[3]  R L Hess,et al.  Improved colorimetric assay for glycosylated hemoglobin. , 1981, Clinical chemistry.

[4]  R N Bergman,et al.  Importance of Glucose Per Se to Intravenous Glucose Tolerance: Comparison of the Minimal-Model Prediction with Direct Measurements , 1985, Diabetes.

[5]  H. Yki-Järvinen,et al.  Natural course of insulin resistance in type I diabetes. , 1986, The New England journal of medicine.

[6]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[7]  D. Finegood,et al.  Insulin Sensitivity and Glucose Effectiveness in Long-Term Islet-Autotransplanted Dogs , 1989, Diabetes.

[8]  M. Entman,et al.  Effects of Portal and Peripheral Venous Insulin Infusion on Glucose Production and Utilization in Depancreatized, Conscious Dogs , 1984, Diabetes.

[9]  Estimates of in vivo insulin action in humans: comparison of the insulin clamp and the minimal model techniques. , 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[10]  W. Fleig,et al.  Modulation by a Sulfonylurea of Insulin-dependent Glycogenesis, but Not of Insulin Binding, in Cultured Rat Hepatocytes: Evidence for a Postreceptor Mechanism of Action , 1984, Diabetes.

[11]  S. B. Lewis,et al.  Acute tolbutamide administration alone or combined with insulin enhances glucose uptake in the perfused rat hindlimb. , 1982, Endocrinology.

[12]  R N Bergman,et al.  Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.

[13]  R N Bergman,et al.  The Insulin Sensitivity Index: Correlation in Dogs Between Values Determined from the Intravenous Glucose Tolerance Test and the Euglycemic Glucose Clamp , 1984, Diabetes.

[14]  J. A. Scarlett,et al.  Lack of in vivo insulin resistance in controlled insulin-dependent, type I, diabetic patients. , 1984, The Journal of clinical endocrinology and metabolism.

[15]  M. Geffner,et al.  Associated non-ovarian problems of polycystic ovarian disease: insulin resistance. , 1985, Clinics in obstetrics and gynaecology.

[16]  R N Bergman,et al.  The Insulin Sensitivity Index in Nondiabetic Man: Correlation Between Clamp-derived and IVGTT-derived Values , 1986, Diabetes.

[17]  A. Matsutani,et al.  Tolbutamide Stimulates Fructose-2, 6-Bisphosphate Formation in Perfused Rat Liver , 1984, Diabetes.

[18]  S. Schaffer,et al.  Effect of Tolbutamide on Myocardial Metabolism and Mechanical Performance of the Diabetic Rat , 1984, Diabetes.

[19]  R. Bergman,et al.  Reduced Insulin Sensitivity in Nondiabetic, HLA-Identical Siblings of Insulin-dependent Diabetic Subjects , 1985, Diabetes.

[20]  R N Bergman,et al.  Modified protocols improve insulin sensitivity estimation using the minimal model. , 1987, The American journal of physiology.

[21]  R N Bergman,et al.  MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. , 1986, Computer methods and programs in biomedicine.

[22]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[23]  R. Mayfield,et al.  Predicting Insulin Requirements for a Portable Insulin Pump Using the Biostator: Evidence for Reversible Insulin Resistance in Poorly Controlled Type I Diabetics , 1983, Diabetes.

[24]  J. Halter,et al.  The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes , 1982, Diabetes.

[25]  H. Yki-Järvinen,et al.  Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. , 1984, The Journal of clinical endocrinology and metabolism.

[26]  A. Laupacis,et al.  Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months. , 1988, Transplantation proceedings.

[27]  R. Bergman,et al.  Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. , 1985, The Journal of clinical endocrinology and metabolism.

[28]  J. Halter,et al.  Insulin Resistance and Impaired Insulin Secretion in Subjects with Histories of Gestational Diabetes Mellitus , 1985, Diabetes.

[29]  R. DeFronzo,et al.  Insulin Resistance is a Prominent Feature of Insulin-dependent Diabetes , 1982, Diabetes.

[30]  G. Reaven,et al.  Presentation of a new method for specific measurement of in vivo insulin-stimulated glucose disposal in humans: comparison of this approach with the insulin clamp and minimal model techniques. , 1985, The Journal of clinical endocrinology and metabolism.

[31]  R. Bergman,et al.  β-Cell Function and Insulin Sensitivity in Nondiabetic HLA-identical Siblings of Insulin-Dependent Diabetics , 1987, Diabetes.

[32]  R. Rizza,et al.  Comparison of Peripheral and Portal Venous Insulin Administration on Postprandial Metabolic Responses in Alloxan-Diabetic Dogs: Effects of Identical Preprogrammed Complex Insulin Infusion Waveforms , 1982, Diabetes.

[33]  C. Cobelli,et al.  Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. , 1983, Journal of Clinical Endocrinology and Metabolism.

[34]  R. Bergman,et al.  Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs. , 1987, Endocrinology.

[35]  Stanton A. Glantz,et al.  Primer of biostatistics : statistical software program version 6.0 , 1981 .

[36]  R N Bergman,et al.  Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. , 1987, The Journal of clinical investigation.